← Leaderboards
Arne Rietsch
Case Western Reserve University
$5,356,051
Attributed
$6,277,603
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $947K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,277,603 · 6
By mechanism
R01$4,513,603 · 2
R21$1,764,000 · 4
Top collaborators
- George R Dubyak2 shared
- Eric Pearlman2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Eric Pearlman$20,900,586
- George R Dubyak$11,095,573
- Liem Duy Nguyen$2,802,112
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsPseudomonas AeruginosaMolecularBacteriaInfectionType Iii Secretion System PathwaySyringesKeratitisVirulenceBlindnessIn VivoProductionCorneaNeutrophilPathogenesisDesignMediatingMutantImmune SystemImmuneReportingPreventVirulence Factors
Grant awards (18)
Pathogenesis of Bacterial Keratitis$676,812
R01 · FY2025 · EY
Role of ExoU island accessory genes in P. aeruginosa virulence$201,250
R21 · FY2025 · AI · contact PI
Pathogenesis of Bacterial Keratitis$705,516
R01 · FY2024 · EY
Role of ExoU island accessory genes in P. aeruginosa virulence$241,500
R21 · FY2024 · AI · contact PI
Host cell factors controlling type III secretion effector translocation$201,250
R21 · FY2023 · AI · contact PI
Host cell factors controlling type III secretion effector translocation$241,500
R21 · FY2022 · AI · contact PI
Development of recombinase-based tools to study established infections$201,250
R21 · FY2021 · AI · contact PI
Development of recombinase-based tools to study established infections$241,375
R21 · FY2020 · AI · contact PI
P. aeruginosa type III secreted effectors in corneal disease$396,250
R01 · FY2019 · EY · contact PI
P. aeruginosa type III secreted effectors in corneal disease$396,250
R01 · FY2018 · EY · contact PI
P. aeruginosa type III secreted effectors in corneal disease$396,250
R01 · FY2017 · EY · contact PI
P. aeruginosa type III secreted effectors in corneal disease$396,250
R01 · FY2016 · EY · contact PI
P. aeruginosa type III secreted effectors in corneal disease$396,250
R01 · FY2015 · EY · contact PI
Type III Secretion Translocon Structure and Function$198,125
R21 · FY2015 · AI · contact PI
P. aeruginosa type III secreted effectors in corneal disease$384,650
R01 · FY2014 · EY · contact PI
Type III Secretion Translocon Structure and Function$237,750
R21 · FY2014 · AI · contact PI
P. aeruginosa type III secreted effectors in corneal disease$372,875
R01 · FY2013 · EY · contact PI
P. aeruginosa type III secreted effectors in corneal disease$392,500
R01 · FY2012 · EY · contact PI